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This Month in the Journal
This month in the Journal, Walter Nance and Michael
Kearsey provide their thoughts on the role of the con-
nexins in human evolution. Previous work from Dr.
Nance’s group suggested that the frequency ofmutations
at the DFNB1 deafness locus, which includes the genes
for connexins 26 and 30, has doubled in the United
States in the past 200 years. Here, they performed simu-
lations indicating that a combination of relaxed selection
and assortative mating due to the development of sign
language could have led to this rapid rise in the incidence
of connexin-associated deafness. This got them to think-
ing about the evolution of speech in general. They pro-
pose that once the ﬁrst mutations for oral communica-
tion arose, assortative mating based on linguistic homog-
amy may have played a role in the accelerated ﬁxation
of genes for speech.
CHEK2*1100delC and Susceptibility to Breast Cancer,
by The CHEK2 Breast Cancer Case-Control
Consortium (p. 1175)
The CHEK2*1100delC mutation abrogates the kinase
function of this protein, which is involved in checkpoint
control and DNA damage repair. This variant is asso-
ciated with increased risk of breast cancer, but robust
estimates of the relative risk it confers in the absence of
family history are lacking. To further examine this as-
sociation, members of the CHEK2 Breast Cancer Case-
Control Consortium combined data from 10 case-con-
trol studies of CHEK2*1100delC, for a total of ∼11,000
cases (that were unselected for family history) and 9,000
controls. The results of this population-based analysis
indicate that carriers of CHEK2*1100delC have an ap-
proximately twofold increased risk of breast cancer, al-
though the risk seems to be greater in women with af-
fected ﬁrst-degree relatives and in those diagnosed at
younger ages. This risk is relativelymodest comparedwith
that conferred by mutations in BRCA1 and BRCA2. At
this point, the authors don’t feel it is appropriate to rou-
tinely test for CHEK2*1100delC, which they estimate
should only be responsible for ∼0.7% of breast cancer
cases, although this ﬁgurewill vary according to the popu-
lation frequency of the variant.
Human Y-Chromosomal Microsatellites, by Kayser et
al. (p. 1183)
Y-chromosomal microsatellites are important markers
used in forensic and phylogenetic studies. To date, only
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53 are known, and this limits the resolution that can be
achieved between lineages. Kayser et al. used the recently
reported Y-chromosome sequence to ﬁnd 166 novel mi-
crosatellites, thereby quadrupling the number of avail-
able markers. Of the novel markers, 139 were polymor-
phic in a sample of eight chromosomes from different
haplogroups. Comparisons of the markers through mul-
tiple linear regressions allowed the authors to determine
that repeat count—or, in the case of complex repeats,
the repeat count of the longest homogeneous array—
appears to explain a large proportion of the repeat vari-
ance in these markers. It is likely that the great majority
of useful microsatellites on the Y chromosome have now
been reported, thereby making it easier for researchers
to select appropriate markers for high-resolution analy-
sis of Y chromosomes.
MSH6 Germline Mutations, by Buttin et al. (p. 1262)
Although germline mutations in the mismatch-repair
gene MSH6 have been found in families with suspected
hereditary nonpolyposis colorectal cancer (HNPCC),
these families often do not meet the classic diagnostic
criteria for this disorder, and many cancers in MSH6
mutation carriers do not exhibit the expected high levels
of microsatellite instability. This makes unclear the exact
role of MSH6 in susceptibility to inherited cancers. To
address this question, Buttin et al. studied seven kindreds
with MSH6 germline mutations. The families were iden-
tiﬁed through probands with endometrial cancer who
were ascertained independent of family history or age
at diagnosis, and the authors gathered information on
cancers in 278 of the probands’ relatives. They found a
signiﬁcant excess of MSH6 mutation carriers among the
affected family members, indicating thatMSH6 germline
mutations are associated with increased cancer risk. Fur-
ther supporting this association is the fact that the rate
of cancers in ﬁrst-degree relatives of the probands with
MSH6 mutations is higher than in relatives of presum-
ably sporadic cases of endometrial cancer. Including the
probands, the overall penetrance of the mutations was
close to 60%, which is higher than previously believed.
It is unfortunate that it is not yet clear which families
should be screened for MSH6 mutations, because they
are not necessarily associated with a family history of
HNPCC, a young age at diagnosis, or microsatellite in-
stability in the tumors.
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Offspring Gender and Miscarriages in BRCA1/2, by
Gal et al. (p. 1270)
A recent article by de la Hoya et al. (see reference in Gal
et al.) analyzed the sex ratio in 68 Spanish pedigrees
with breast and/or ovarian cancer and found that, in the
pedigrees segregatingBRCA1mutations, therewas strong
skewing of the sex ratio (2:1) against males. This skew-
ing was not seen in a sample of families with BRCA2
mutations, nor in those without a detectable mutation
in either gene. Gal et al. were interested in this ﬁnding
and wondered whether similar results could be found in
an Ashkenazi Jewish sample, which should have a high
proportion of BRCA1 and BRCA2 mutations. As in the
study by de la Hoya et al., all women in the sample of
Gal et al. were at high risk of familial breast and ovarian
cancer. Comparisons were made between those women
with and those without the three predominant Jewish
mutations in BRCA1 and BRCA2. Unlike the study by
de la Hoya et al., no difference in the male:female off-
spring ratio was observed, but an explanation for the
conﬂicting results between the Spanish and Israeli Jew-
ish populations is not clear. Because no homozygous
BRCA1/2 mutation carriers have ever been reported, de-
spite relatively high mutation frequencies, Gal et al. also
wondered whether the BRCA1/2 mutation carriers in
their sample had increased rates of recurrent sponta-
neous miscarriage that could represent inviability of ho-
mozygous fetuses. No differences in the rates of recurrent
spontaneous miscarriage were found between mutation
carriers and noncarriers. However, both groups had
higher rates of recurrent miscarriage than have been re-
ported for an average risk population, so additional fol-
low-up in this area is needed.
Chromosomal Abnormalities, by Winther et al. (p.
1282)
The chemotherapeutic agents and radiation used to treat
childhood cancers are capable of inducing mutations,
but it is not absolutely clear whether treatment with these
agents will affect the future children of cancer survivors.
Winther et al. used the extensive Danish health care reg-
istries to do a population-based study of this problem.
They found 4,676 cancer survivors in the Danish Cancer
Registry who were diagnosed at age !20 years and who
survived to the onset of fertility. By connecting this in-
formation with data from the Danish Cytogenetic Reg-
istry, Winther et al. could compare the rates of chromo-
somal aberrations in the survivors’ offspring with those
in the offspring of the survivors’ 6,441 siblings. No dif-
ferences in the proportions of liveborn children with
chromosome abnormalities were observed,which should
provide further reassurance to cancer survivors who are
contemplating having kids.
Bias Dependent on Test Statistic Used, by Cordell (p.
1294)
In a recent article, Schork and Greenwood (Am J Hum
Genet 74:306–316) suggested that nonparametric (model-
free) linkage analyses can show a bias toward the null
hypothesis of no effect because uninformative relative
pairs are assigned expected allele-sharing values.This con-
clusion turned out to be quite controversial, because it
was interpreted by some as a criticism of model-free
analysis methods in general, especially since the authors
suggested that researchers who have used these methods
should revisit their results. In this issue, Heather Cordell
examines the extent of this problem and shows thatmost
of the test statistics available in standard linkage analysis
packages (such as Genehunter, Merlin, and Allegro) are,
in fact, not affected, because they do not assign expected
allele-sharing values to uninformative relative pairs but
rather allow for uncertainty in identity-by-descent shar-
ing. She points out that the conclusions made by Schork
and Greenwood result, in part, from the test statistic they
chose to investigate. Schork and Greenwood admitted in
their article that their simulation study was explicitly con-
structed as a worst-case scenario to demonstrate the bias.
An examination of some of the more complex linkage
methods for analysis of qualitative and quantitative traits
showed that, although some statistics can be affected,
methods exist in the literature to overcome the problem.
Although this was not an exhaustive study, in terms of
the statistics tested, this work should serve to clarify the
situations in which the bias could be a concern.
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